Back to calendar
Aligos Therapeutics, Inc. (ALGS) Earnings
ALGS reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-1.00
Actual EPS: $-2.21
EPS surprise: 0.15%
Company overview
Market Cap$41.0M
PriceUSD 6.62
EPS (TTM)-8.70
52-week high13.69
52-week low4.80
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees82